These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 16753017)

  • 1. Mice lacking cathepsin K maintain bone remodeling but develop bone fragility despite high bone mass.
    Li CY; Jepsen KJ; Majeska RJ; Zhang J; Ni R; Gelb BD; Schaffler MB
    J Bone Miner Res; 2006 Jun; 21(6):865-75. PubMed ID: 16753017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone density, strength, and formation in adult cathepsin K (-/-) mice.
    Pennypacker B; Shea M; Liu Q; Masarachia P; Saftig P; Rodan S; Rodan G; Kimmel D
    Bone; 2009 Feb; 44(2):199-207. PubMed ID: 18845279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased fracture callus mineralization and strength in cathepsin K knockout mice.
    Gentile MA; Soung do Y; Horrell C; Samadfam R; Drissi H; Duong LT
    Bone; 2014 Sep; 66():72-81. PubMed ID: 24928497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered hematopoietic stem cell and osteoclast precursor frequency in cathepsin K null mice.
    Jacome-Galarza C; Soung do Y; Adapala NS; Pickarski M; Sanjay A; Duong LT; Lorenzo JA; Drissi H
    J Cell Biochem; 2014 Aug; 115(8):1449-57. PubMed ID: 24590570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functions of cathepsin K in bone resorption. Lessons from cathepsin K deficient mice.
    Saftig P; Hunziker E; Everts V; Jones S; Boyde A; Wehmeyer O; Suter A; von Figura K
    Adv Exp Med Biol; 2000; 477():293-303. PubMed ID: 10849757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin-K-deficient mice.
    Saftig P; Hunziker E; Wehmeyer O; Jones S; Boyde A; Rommerskirch W; Moritz JD; Schu P; von Figura K
    Proc Natl Acad Sci U S A; 1998 Nov; 95(23):13453-8. PubMed ID: 9811821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired bone resorption in cathepsin K-deficient mice is partially compensated for by enhanced osteoclastogenesis and increased expression of other proteases via an increased RANKL/OPG ratio.
    Kiviranta R; Morko J; Alatalo SL; NicAmhlaoibh R; Risteli J; Laitala-Leinonen T; Vuorio E
    Bone; 2005 Jan; 36(1):159-72. PubMed ID: 15664014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cathepsin K Deficiency Suppresses Disuse-Induced Bone Loss.
    Moriya S; Izu Y; Arayal S; Kawasaki M; Hata K; Pawaputanon Na Mahasarakhahm C; Izumi Y; Saftig P; Kaneko K; Noda M; Ezura Y
    J Cell Physiol; 2016 May; 231(5):1163-70. PubMed ID: 26460818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infant cynomolgus monkeys exposed to denosumab in utero exhibit an osteoclast-poor osteopetrotic-like skeletal phenotype at birth and in the early postnatal period.
    Boyce RW; Varela A; Chouinard L; Bussiere JL; Chellman GJ; Ominsky MS; Pyrah IT
    Bone; 2014 Jul; 64():314-25. PubMed ID: 24727159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cathepsin K knockout mice develop osteopetrosis due to a deficit in matrix degradation but not demineralization.
    Gowen M; Lazner F; Dodds R; Kapadia R; Feild J; Tavaria M; Bertoncello I; Drake F; Zavarselk S; Tellis I; Hertzog P; Debouck C; Kola I
    J Bone Miner Res; 1999 Oct; 14(10):1654-63. PubMed ID: 10491212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cathepsin K deficiency partially inhibits, but does not prevent, bone destruction in human tumor necrosis factor-transgenic mice.
    Schurigt U; Hummel KM; Petrow PK; Gajda M; Stöckigt R; Middel P; Zwerina J; Janik T; Bernhardt R; Schüler S; Scharnweber D; Beckmann F; Saftig P; Kollias G; Schett G; Wiederanders B; Bräuer R
    Arthritis Rheum; 2008 Feb; 58(2):422-34. PubMed ID: 18240253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High bone mineral density in pycnodysostotic patients with a novel mutation in the propeptide of cathepsin K.
    Schilling AF; Mülhausen C; Lehmann W; Santer R; Schinke T; Rueger JM; Amling M
    Osteoporos Int; 2007 May; 18(5):659-69. PubMed ID: 17206399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel role for cathepsin K in periosteal osteoclast precursors during fracture repair.
    Walia B; Lingenheld E; Duong L; Sanjay A; Drissi H
    Ann N Y Acad Sci; 2018 Mar; 1415(1):57-68. PubMed ID: 29479711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in osteoclast biology resulting from the study of osteopetrotic mutations.
    Segovia-Silvestre T; Neutzsky-Wulff AV; Sorensen MG; Christiansen C; Bollerslev J; Karsdal MA; Henriksen K
    Hum Genet; 2009 Jan; 124(6):561-77. PubMed ID: 18987890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preservation of type H vessels and osteoblasts by enhanced preosteoclast platelet-derived growth factor type BB attenuates glucocorticoid-induced osteoporosis in growing mice.
    Yang P; Lv S; Wang Y; Peng Y; Ye Z; Xia Z; Ding G; Cao X; Crane JL
    Bone; 2018 Sep; 114():1-13. PubMed ID: 29800693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cathepsin K Controls Cortical Bone Formation by Degrading Periostin.
    Bonnet N; Brun J; Rousseau JC; Duong LT; Ferrari SL
    J Bone Miner Res; 2017 Jul; 32(7):1432-1441. PubMed ID: 28322464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The resorptive apparatus of osteoclasts supports lysosomotropism and increases potency of basic versus non-basic inhibitors of cathepsin K.
    Fuller K; Lindstrom E; Edlund M; Henderson I; Grabowska U; Szewczyk KA; Moss R; Samuelsson B; Chambers TJ
    Bone; 2010 May; 46(5):1400-7. PubMed ID: 20097319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of pharmacological inhibition of cathepsin K on fracture repair in mice.
    Soung do Y; Gentile MA; Duong LT; Drissi H
    Bone; 2013 Jul; 55(1):248-55. PubMed ID: 23486186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of altered bone remodeling and retention of cement lines on bone quality in osteopetrotic aged c-Src-deficient mice.
    Nakayama H; Takakuda K; Matsumoto HN; Miyata A; Baba O; Tabata MJ; Ushiki T; Oda T; McKee MD; Takano Y
    Calcif Tissue Int; 2010 Feb; 86(2):172-83. PubMed ID: 20063091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deficiency and inhibition of cathepsin K reduce body weight gain and increase glucose metabolism in mice.
    Yang M; Sun J; Zhang T; Liu J; Zhang J; Shi MA; Darakhshan F; Guerre-Millo M; Clement K; Gelb BD; Dolgnov G; Shi GP
    Arterioscler Thromb Vasc Biol; 2008 Dec; 28(12):2202-8. PubMed ID: 18818416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.